2021
December
01,
2021
|
14:00 PM
Europe/Amsterdam
The Consumer Health division accelerates the execution of its sustainability program and strikes partnership for collective action across the self care industry
Read more
September
22,
2021
|
09:00 AM
Europe/Amsterdam
Initial product offering will focus on key crops for greenhouse and glasshouse markets: tomato, sweet pepper and cucumber / Commercial launch is slated for 2022 in Canada, US, Mexico, Spain and Italy with potential for future expansion...
Read more
February
02,
2021
|
14:00 PM
Europe/Amsterdam
Primary Focus will be on Most Vulnerable - Pregnant Women and Children in Underserved Communities
Read more
2020
April
21,
2020
|
14:30 PM
Europe/Amsterdam
Investigation of combination therapies including Bayer’s chloroquine and interferon beta-1b to foster much needed solutions for patients in fight against coronavirus pandemic / Bayer Canada to make CAD 1.5 million (approximately 1 million euros) fina...
Read more
2019
July
02,
2019
|
09:00 AM
Europe/Amsterdam
Ballerup, Denmark / Leverkusen, Germany, July 2, 2019 - LEO Pharma and Bayer announced today the achievement of the relevant closing conditions to allow the transfer of Bayer’s global prescription dermatology business to LEO Pharma. The companies fir...
Read more
2018
November
27,
2018
|
15:30 PM
Europe/Amsterdam
The safety and efficacy profile of Jivi has been demonstrated in more than five years of clinical studies / Prophylaxis with Jivi enables sustained factor VIII concentrations in the blood over time
Read more
2017
August
07,
2017
|
08:30 AM
Europe/Amsterdam
Approval marks first treatment advance in nearly a decade and is based on data from the Phase III RESORCE study, in which Stivarga® (regorafenib) demonstrated significant improvement in overall survival in hepatocellular carcinoma (HCC) patients prev...
Read more
